Valkyrie Pharma has not been perfect lately but its testosterone enanthate product remains accurately dosed.
Valkyrie Pharma has generally done well on AnabolicLab.com. This is why it was a big surprise that its Susta 300 performed so poorly in recent analytical testing. But its Testosterone Enanthate product lab test results are more in line with what we have come to expect.
Valkyrie Pharmaceutical Testosterone E250 supposedly contains 250 milligrams of testosterone enanthate per milliliter of injectable solution according to the product label. AnabolicLab verified this claim by submitting an unopened sample to SIMEC for laboratory analysis.
New lab report: Valkyrie Pharmaceutical Testosterone E250 Lab Test Results https://t.co/E3S1RBzLdb #harmreduction #steroids
— Anabolic Lab (@AnabolicLab) May 3, 2019
Valkyrie Pharma Testosterone E250 has been accurately dosed in multiple steroid analytics over the past couple of years.
The lab test results revealed that Valkyrie Pharma Testosterone E250 actually contained 229.4 mg/ml of testosterone enanthate. This falls well within 10% of the label claim.
Valkyrie Pharma Testosterone E250 easily passed the AnabolicLab criteria of 20%. It also passed Roidvisor’s preference for products within 10% of label claim.
This is the second time Valkyrie Pharma Testosterone E250 has been tested by AnabolicLab. AnabolicLab first analyzed the product in September 2016.
The September 2016 lab test results revealed dosage quantification of 281.8 mg/ml of testosterone enanthate. This placed it at approximately 13% overdosed. It easily passed AnabolicLab’s criteria.
AnabolicLab’s decision to analyze different batches of the same product over time is a great way to monitor the consistency of a brand’s products.
